Overview

Examining the Link Between Obesity, Inflammation, and Response to Asthma Medications

Status:
Completed
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
Asthma is a common, long-term disease that is caused by inflammation of the airways. Inflammation also plays a role in obesity and may affect the way a person responds to asthma medication. This study will examine the relationship between obesity and inflammation and the effect they have on response to corticosteroid asthma medications.
Details
Lead Sponsor:
National Jewish Health
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Treatments:
Beclomethasone
Bromides
Salmeterol Xinafoate
Tiotropium Bromide